Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ambiante Health & Wellness vs Ark Health

Ambiante Health & Wellness
Graded #448

Lower grade

vs+1.7999999999999972
Ark Health
Graded #406

Higher grade

The verdict

Ark Health takes it — 56.8/100 to 55/100, but only just.

Ark Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ark Health is a national direct-to-consumer telehealth platform with one of the widest menus in the directory — compounded semaglutide ($169/mo), tirzepatide ($249/mo) and oral semaglutide ($125/mo), plus… Ambiante Health & Wellness is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmbiante Health & Wellness +11
45
34
Dose & formulationArk Health +48
40
88
Clinical oversightAmbiante Health & Wellness +19
78
59
Labs & monitoringAmbiante Health & Wellness +1
53
52
FulfillmentAmbiante Health & Wellness +9
65
56
Contract termsEven
55
55
Ambiante Health & Wellness · left barArk Health · right bar

The numbers

MetricAmbiante Health & WellnessArk Health
WeighScore55/10056.8/100
GradeCC
Scorecard rank#448#406
SemaglutideNot disclosed$1,399/mo (brand Ozempic)
TirzepatideNot disclosed$1,499/mo (brand Mounjaro)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes

Strengths

  • Compounded semaglutide and tirzepatide plus a low-dose GLP-1 "Longevity Microdose" option, all provider-guided
  • Concierge model: dedicated provider, direct secure messaging, provider-directed dosing, and structured check-ins
  • Every plan bundles compounded medication, provider care, and discreet direct delivery with no hidden fees
  • No charge if you are not approved; published support hours (Mon-Fri, 9am-5pm ET) by phone and email

Where it loses points

  • GLP-1 program pricing is not published on the site — quoted only after provider review, so cost is not comparable up front
  • Compounding pharmacy partners are not publicly named (a transparency gap for medication sourcing)
  • No brand-name Wegovy, Zepbound, Mounjaro, or Ozempic — compounded formulations only
  • State availability is not published; private-pay only, and the practice serves women, so it is not a fit for everyone
  • No LegitScript or PCAB accreditation displayed on the marketing site
Ark Health

Graded #406 · C

Strengths

  • Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
  • Consistent pricing at all dosages — flat rate, no escalation as you titrate up
  • Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
  • Free expedited shipping included
  • Phone support published (uncommon among DTC platforms)

Where it loses points

  • States served not listed — can't confirm coverage in your state without contacting support
  • LegitScript status not disclosed — no badge or verifiable ID
  • FDA compounded-medication disclaimer not displayed
  • Medical director / clinical lead not named — only generic 'certified healthcare providers'
  • Pharmacy partner not named; 503A vs 503B unspecified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard